Posts by: Diana Campelo Delgado

Diana Campelo Delgado

Diana holds a PhD in Biomedical Sciences, with specialization in genetics, from Universidade Nova de Lisboa, Portugal. Her work has been focused on enzyme function, human genetics and drug metabolism.

February 22, 2021February 22, 2021

Cure Parkinson’s Grant Supports Potential Iron-trapping Treatment

News

Cure Parkinson’s is supporting AbFero Pharmaceuticals in its work to advance SP-420, a potential disease-modifying therapy for Parkinson’s disease that clears excess iron from the brain. The grant award supports further testing of AbFero’s lead compound ... Read more

February 19, 2021February 19, 2021

Dosing Begins in Early Trial of Oral Therapy to Protect Dopaminergic Neurons

News

Dosing has begun in a Phase 1 clinical trial testing Inhibikase Therapeutics’ investigational oral therapy IkT-148009 for Parkinson’s disease and related disorders in healthy volunteers. This first clinical trial (NCT04350177) ... Read more

February 18, 2021February 18, 2021

SITraN, Verge Partner to Develop, Advance to Trial New Therapeutic Targets

News

The Sheffield Institute for Translational Neuroscience, known as SITraN, has joined with Verge Genomics to develop new therapeutic targets and screen the latest compounds for the treatment of neurodegenerative disorders ... Read more

February 17, 2021February 17, 2021

Mobile Parkapp Will Monitor, Help Diagnose Parkinson’s

News

Researchers from Malmö University in Sweden are developing an interactive digital health tool, called Parkapp, to monitor symptoms and help diagnose Parkinson’s disease. The mobile app is able to monitor ... Read more

February 16, 2021February 16, 2021

China Approves MR-guided Focused Ultrasound to Treat Tremors

News

Insightec announced that its incision-free brain “surgery” technology — called Exablate 4000 (Exablate Neuro) — has been approved in China to treat essential tremor and tremors caused by Parkinson’s disease. The market ... Read more

February 15, 2021February 15, 2021

MJFF $495K Grant to Help Move Alterity’s Potential Oral Therapy Into Trials

News

Alterity Therapeutics has been awarded a grant from the Michael J. Fox Foundation (MJFF) for animal studies to determine the optimal dose its of lead candidate ATH434, an essential step ... Read more

February 10, 2021February 10, 2021

Newronika’s AlphaDBS System Implanted in First Patient

News

The first Parkinson’s disease patient has been implanted with Newronika‘s AlphaDBS, an innovative deep brain stimulation (DBS) system, in a clinical trial conducted in Italy and Poland. DBS is an established treatment ... Read more

February 1, 2021February 1, 2021

AskBio Acquires BNB and Gene Therapy Now in Parkinson’s Trials

News

Brain Neurotherapy Bio (BNB) has joined with Asklepios BioPharmaceutical (AskBio), a merger aiming to expand a gene therapy program for progressive neurodegenerative diseases such as Parkinson’s and multiple system atrophy (MSA), a ... Read more

January 28, 2021January 28, 2021

Manus Raises £1.2M to Launch NeuroMotor Pen, Tool for Early Diagnosis

News

Manus Neurodynamica, a medical technology company, has raised £1.2 million ($1.6 million) to launch NeuroMotor, a digital pen with a patented sensor technology that can help diagnose patients with Parkinson’s ... Read more

January 28, 2021January 28, 2021

Microba, Scientists See Road to Treatment Starting in Patients’ Gut

News

Microba has partnered with researchers at the University of Queensland’s (UQ) Faculty of Medicine to study gut bacteria of people with Parkinson’s disease, with a goal of discovering and developing new ... Read more